---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-037237"
form_type: "8-K"
ticker: "RCKT"
cik: "0001281895"
company_name: "ROCKET PHARMACEUTICALS, INC."
filed_at: "2025-10-03T23:59:59+00:00"
generated_at: "2026-05-17T04:42:40.988355+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Director Pedro Granadillo resigns from Rocket Pharmaceuticals board effective Sept 30, 2025

## Summary
- Pedro Granadillo resigned from Board on Sept 29, 2025, effective Sept 30, 2025.
- Resignation not due to any disagreement on operations, policies, or practices.
- No replacement announced; remaining directors continue.

## SEC filing metadata
- accession: 0001140361-25-037237
- form_type: 8-K
- ticker: RCKT
- cik: 0001281895
- company_name: ROCKET PHARMACEUTICALS, INC.
- filed_at: 2025-10-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1281895/000114036125037237/0001140361-25-037237-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1281895/000114036125037237/ef20056614_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-037237
- JSON: https://secwatch.observer/filing/0001140361-25-037237.json
- Plain text: https://secwatch.observer/filing/0001140361-25-037237.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.